| Patent | Date |
|---|
Stratification of pancreatic and ovarian cancer patients for susceptibility to therapy with PTK2 inhibitors
Grant 9,274,120 - Adolf , et al. March 1, 2 | 2016-03-01 |
Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
App 20140205592 - ADOLF; Guenther ; et al. | 2014-07-24 |
Combination Therapy In Treatment Of Oncological And Fibrotic Diseases
App 20140187563 - VAN RYN; Joanne ; et al. | 2014-07-03 |
Combination Therapy In Treatment Of Cancer And Fibrotic Diseases
App 20140066456 - VAN RYN; Joanne ; et al. | 2014-03-06 |
Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
App 20120244141 - ADOLF; Guenther ; et al. | 2012-09-27 |
New Combination Therapy In Treatment Of Oncological And Fibrotic Diseases
App 20120142703 - Van Ryn; Joanne ; et al. | 2012-06-07 |
New Combination Therapy In Treatment Of Cancer And Fibrotic Diseases
App 20120136004 - Van Ryn; Joanne ; et al. | 2012-05-31 |
Pyrrolobenzimidazolones and their use as anti-proliferative agents
Grant 7,714,010 - McConnel , et al. May 11, 2 | 2010-05-11 |
Pyrrolobenzimidazolones and their use as anti-proliferative agents
App 20050261350 - McConnel, Darryl ; et al. | 2005-11-24 |
FAP-activated anti-tumor compounds
App 20030232742 - Peters, Stefan ; et al. | 2003-12-18 |
FAP-activated anti-tumor compounds
App 20030211979 - Blech, Stefan ; et al. | 2003-11-13 |
FAP-activated anti-tumour compounds
Grant 6,613,879 - Firestone , et al. September 2, 2 | 2003-09-02 |
FAPalpha -specific antibody with improved producibility
App 20030143229 - Park, John Edward ; et al. | 2003-07-31 |
FAP-activated anti-tumor compounds
App 20030055052 - Peters, Stefan ; et al. | 2003-03-20 |
Recombinant human anti-Lewis Y antibodies
Grant 6,518,415 - Armour , et al. February 11, 2 | 2003-02-11 |
FAP-activated anti-tumor compounds
App 20020155565 - Garin-Chesa, Pilar ; et al. | 2002-10-24 |
FAP.alpha.-specific antibody with improved producibility
Grant 6,455,677 - Park , et al. September 24, 2 | 2002-09-24 |
Human FAP-alpha-specific antibodies
App 20020099180 - Pfizenmaier, Klaus ; et al. | 2002-07-25 |
Method for treating cancers which present antigen FB5 with humanized antibodies
Grant 6,391,302 - Wallace , et al. May 21, 2 | 2002-05-21 |
Fapalpha-specific Antibody With Improved Producibility
App 20020052480 - PARK, JOHN EDWARD ; et al. | 2002-05-02 |
Method for treating cancers
Grant 6,348,195 - Wallace , et al. February 19, 2 | 2002-02-19 |
Recombinant human anti-Lewis Y antibodies
Grant 6,310,185 - Wallace , et al. October 30, 2 | 2001-10-30 |
Methods for detecting cancer cells by using humanized antibodies which bind specifically to FB5 antigen
Grant 6,217,868 - Wallace , et al. April 17, 2 | 2001-04-17 |
Method for detecting cancers
Grant 6,124,106 - Wallace , et al. September 26, 2 | 2000-09-26 |
Recombinant human anti-LK26 antibodies
Grant 5,952,484 - Wallace , et al. September 14, 1 | 1999-09-14 |
Recombinant human anti-Lewis Y antibodies
Grant 5,874,060 - Armour , et al. February 23, 1 | 1999-02-23 |
Recombinant humanized anti-FB5 antibodies
Grant 5,811,522 - Wallace , et al. September 22, 1 | 1998-09-22 |
Recombinant human anti-LK26 antibodies
Grant 5,646,253 - Wallace , et al. July 8, 1 | 1997-07-08 |
Isolated sialylated glycoprotein endosialin, which is expressed by tumor associated vascular endothelium
Grant 5,437,865 - Garin-Chesa , et al. August 1, 1 | 1995-08-01 |
Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof
Grant 5,342,757 - Garin-Chesa , et al. August 30, 1 | 1994-08-30 |
Cell-surface glycoproteins of human sarcomas
Grant 5,059,523 - Rettig , et al. October 22, 1 | 1991-10-22 |
| 